{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:14:17Z","timestamp":1791083657316,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL142494"],"award-info":[{"award-number":["P01HL142494"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS125353"],"award-info":[{"award-number":["R01NS125353"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DP2CA281401"],"award-info":[{"award-number":["DP2CA281401"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K01NS134784"],"award-info":[{"award-number":["K01NS134784"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS125353"],"award-info":[{"award-number":["R01NS125353"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS125353"],"award-info":[{"award-number":["R01NS125353"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01499-1","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:02:39Z","timestamp":1757581359000},"page":"952-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Treatment of a severe vascular disease using a bespoke CRISPR\u2013Cas9 base editor in mice"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-9689","authenticated-orcid":false,"given":"Christiano R. R.","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabyasachi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijai","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-660X","authenticated-orcid":false,"given":"Leillani L.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Stutzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Shamber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pazhanichamy","family":"Kalailingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-4375","authenticated-orcid":false,"given":"Christian L.","family":"Lino Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunayana","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael K.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike M. C.","family":"Benning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangsan","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ferreira da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demitri","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Richa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-1567","authenticated-orcid":false,"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-3159","authenticated-orcid":false,"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0120-4630","authenticated-orcid":false,"given":"Rajeev","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-5851","authenticated-orcid":false,"given":"David Y.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-4148","authenticated-orcid":false,"given":"Luke H.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-3993","authenticated-orcid":false,"given":"Shengdar Q.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8681-5179","authenticated-orcid":false,"given":"Casey A.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6724-7938","authenticated-orcid":false,"given":"Mark E.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5469-0655","authenticated-orcid":false,"given":"Benjamin P.","family":"Kleinstiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-5649","authenticated-orcid":false,"given":"Patricia L.","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"1499_CR1","first-page":"e93","volume":"147","author":"T Cw","year":"2023","unstructured":"Cw, T. et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147, e93\u2013e621 (2023).","journal-title":"Circulation"},{"key":"1499_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2023.08.026","volume":"149","author":"BEL Ostrem","year":"2023","unstructured":"Ostrem, B. E. L., Godfrey, D., Caruso, P. A. & Musolino, P. L. Monogenic causes of cerebrovascular disease in childhood: a case series. Pediatr. Neurol. 149, 39\u201343 (2023).","journal-title":"Pediatr. Neurol."},{"key":"1499_CR3","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/ijms23031601","volume":"23","author":"M Jankovic","year":"2022","unstructured":"Jankovic, M. et al. The genetic basis of strokes in pediatric populations and insight into new therapeutic options. Int. J. Mol. Sci. 23, 1601 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1499_CR4","doi-asserted-by":"publisher","first-page":"104030","DOI":"10.1016\/j.ejmg.2020.104030","volume":"63","author":"A Grossi","year":"2020","unstructured":"Grossi, A. et al. Targeted re-sequencing in pediatric and perinatal stroke. Eur. J. Med. Genet. 63, 104030 (2020).","journal-title":"Eur. J. Med. Genet."},{"key":"1499_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41431-018-0274-4","volume":"27","author":"A Ilinca","year":"2019","unstructured":"Ilinca, A. et al. A stroke gene panel for whole-exome sequencing. Eur. J. Hum. Genet. 27, 317\u2013324 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"1499_CR6","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/brain\/aws172","volume":"135","author":"P Munot","year":"2012","unstructured":"Munot, P. et al. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain J. Neurol. 135, 2506\u20132514 (2012).","journal-title":"Brain J. Neurol."},{"key":"1499_CR7","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/ajmg.a.33657","volume":"152A","author":"DM Milewicz","year":"2010","unstructured":"Milewicz, D. M. et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am. J. Med. Genet. A. 152A, 2437\u20132443 (2010).","journal-title":"Am. J. Med. Genet. A."},{"key":"1499_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ajmg.a.35206","volume":"158A","author":"J Richer","year":"2012","unstructured":"Richer, J. et al. R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations. Am. J. Med. Genet. A. 158A, 664\u2013668 (2012).","journal-title":"Am. J. Med. Genet. A."},{"key":"1499_CR9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/gim.2017.245","volume":"20","author":"ES Regalado","year":"2018","unstructured":"Regalado, E. S. et al. Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations. Genet. Med. 20, 1206\u20131215 (2018).","journal-title":"Genet. Med."},{"key":"1499_CR10","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1212\/WNL.0000000000011210","volume":"96","author":"A Lauer","year":"2021","unstructured":"Lauer, A. et al. Cerebrovascular disease progression in patients with ACTA2 Arg179 pathogenic variants. Neurology 96, e538\u2013e552 (2021).","journal-title":"Neurology"},{"key":"1499_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"1499_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"1499_CR13","doi-asserted-by":"publisher","first-page":"aaf8729","DOI":"10.1126\/science.aaf8729","volume":"353","author":"K Nishida","year":"2016","unstructured":"Nishida, K. et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353, aaf8729 (2016).","journal-title":"Science"},{"key":"1499_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770\u2013788 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1499_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli, N. M. et al. Directed evolution of adenine base editors with increased activity and therapeutic application. Nat. Biotechnol. 38, 892\u2013900 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41596-020-00450-9","volume":"16","author":"TP Huang","year":"2021","unstructured":"Huang, T. P., Newby, G. A. & Liu, D. R. Precision genome editing using cytosine and adenine base editors in mammalian cells. Nat. Protoc. 16, 1089\u20131128 (2021).","journal-title":"Nat. Protoc."},{"key":"1499_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"1499_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41587-020-0412-8","volume":"38","author":"SM Miller","year":"2020","unstructured":"Miller, S. M. et al. Continuous evolution of SpCas9 variants compatible with non-G PAMs. Nat. Biotechnol. 38, 471\u2013481 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu, H. et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361, 1259\u20131262 (2018).","journal-title":"Science"},{"key":"1499_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR\u2013Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"1499_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41551-023-01132-z","volume":"8","author":"CRR Alves","year":"2024","unstructured":"Alves, C. R. R. et al. Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy. Nat. Biomed. Eng. 8, 118\u2013131 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"1499_CR23","doi-asserted-by":"publisher","first-page":"eadj6779","DOI":"10.1126\/scitranslmed.adj6779","volume":"16","author":"V Bzhilyanskaya","year":"2024","unstructured":"Bzhilyanskaya, V. et al. High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease. Sci. Transl. Med. 16, eadj6779 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1499_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M. & Yeo, G. W. Base editing: advances and therapeutic opportunities. Nat. Rev. Drug Discov. 19, 839\u2013859 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1499_CR26","doi-asserted-by":"publisher","first-page":"e3002071","DOI":"10.1371\/journal.pbio.3002071","volume":"21","author":"EM Porto","year":"2023","unstructured":"Porto, E. M. & Komor, A. C. In the business of base editors: evolution from bench to bedside. PLoS Biol. 21, e3002071 (2023).","journal-title":"PLoS Biol."},{"key":"1499_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.tig.2021.09.002","volume":"37","author":"KA Christie","year":"2021","unstructured":"Christie, K. A. & Kleinstiver, B. P. Making the cut with PAMless CRISPR-Cas enzymes. Trends Genet. 37, 1053\u20131055 (2021).","journal-title":"Trends Genet."},{"key":"1499_CR28","doi-asserted-by":"publisher","first-page":"eaau0766","DOI":"10.1126\/sciadv.aau0766","volume":"4","author":"P Chatterjee","year":"2018","unstructured":"Chatterjee, P., Jakimo, N. & Jacobson, J. M. Minimal PAM specificity of a highly similar SpCas9 ortholog. Sci. Adv. 4, eaau0766 (2018).","journal-title":"Sci. Adv."},{"key":"1499_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41829-y","volume":"14","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. PAM-flexible genome editing with an engineered chimeric Cas9. Nat. Commun. 14, 6175 (2023).","journal-title":"Nat. Commun."},{"key":"1499_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","volume":"29","author":"AC Chai","year":"2023","unstructured":"Chai, A. C. et al. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice. Nat. Med. 29, 401\u2013411 (2023).","journal-title":"Nat. Med."},{"key":"1499_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.ade1105","volume":"379","author":"S Lebek","year":"2023","unstructured":"Lebek, S. et al. Ablation of CaMKII\u03b4 oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Science 379, 179\u2013185 (2023).","journal-title":"Science"},{"key":"1499_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47830-3","volume":"15","author":"GN Hibshman","year":"2024","unstructured":"Hibshman, G. N. et al. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Nat. Commun. 15, 3663 (2024).","journal-title":"Nat. Commun."},{"key":"1499_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"1499_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P. et al. High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490\u2013495 (2016).","journal-title":"Nature"},{"key":"1499_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17081-y","volume":"7","author":"JM Spencer","year":"2017","unstructured":"Spencer, J. M. & Zhang, X. Deep mutational scanning of S. pyogenes Cas9 reveals important functional domains. Sci. Rep. 7, 16836 (2017).","journal-title":"Sci. Rep."},{"key":"1499_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molcel.2016.02.020","volume":"61","author":"C Anders","year":"2016","unstructured":"Anders, C., Bargsten, K. & Jinek, M. Structural plasticity of PAM recognition by engineered variants of the rna-guided endonuclease Cas9. Mol. Cell 61, 895\u2013902 (2016).","journal-title":"Mol. Cell"},{"key":"1499_CR37","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41596-020-00465-2","volume":"16","author":"RT Walton","year":"2021","unstructured":"Walton, R. T., Hsu, J. Y., Joung, J. K. & Kleinstiver, B. P. Scalable characterization of the PAM requirements of CRISPR\u2013Cas enzymes using HT-PAMDA. Nat. Protoc. 16, 1511\u20131547 (2021).","journal-title":"Nat. Protoc."},{"key":"1499_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41587-019-0254-4","volume":"37","author":"HS Kim","year":"2019","unstructured":"Kim, H. S., Jeong, Y. K., Hur, J. K., Kim, J.-S. & Bae, S. Adenine base editors catalyze cytosine conversions in human cells. Nat. Biotechnol. 37, 1145\u20131148 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR40","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41587-021-00943-2","volume":"39","author":"YK Jeong","year":"2021","unstructured":"Jeong, Y. K. et al. Adenine base editor engineering reduces editing of bystander cytosines. Nat. Biotechnol. 39, 1426\u20131433 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2020.05.037","volume":"182","author":"M Arbab","year":"2020","unstructured":"Arbab, M. et al. Determinants of base editing outcomes from target library analysis and machine learning. Cell 182, 463\u2013480.e30 (2020).","journal-title":"Cell"},{"key":"1499_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41587-023-01792-x","volume":"42","author":"N Kim","year":"2024","unstructured":"Kim, N. et al. Deep learning models to predict the editing efficiencies and outcomes of diverse base editors. Nat. Biotechnol. 42, 484\u2013497 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03394-7","volume":"9","author":"Lino","year":"2018","unstructured":"Lino et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat. Commun. 9, 1009 (2018).","journal-title":"Nat. Commun."},{"key":"1499_CR44","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41588-019-0514-8","volume":"51","author":"R Malhotra","year":"2019","unstructured":"Malhotra, R. et al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat. Genet. 51, 1580\u20131587 (2019).","journal-title":"Nat. Genet."},{"key":"1499_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124706","volume":"4","author":"CL Lino Cardenas","year":"2019","unstructured":"Lino Cardenas, C. L. et al. HDAC9 complex inhibition improves smooth muscle-dependent stenotic vascular disease. JCI Insight 4, e124706 (2019).","journal-title":"JCI Insight"},{"key":"1499_CR46","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/ATVBAHA.122.317953","volume":"42","author":"EL Chou","year":"2022","unstructured":"Chou, E. L. et al. Aortic cellular diversity and quantitative genome-wide association study trait prioritization through single-nuclear RNA sequencing of the aneurysmal human aorta. Arterioscler. Thromb. Vasc. Biol. 42, 1355\u20131374 (2022).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1499_CR47","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1499_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR\u2013Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR49","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/s41596-021-00626-x","volume":"16","author":"NL Malinin","year":"2021","unstructured":"Malinin, N. L. et al. Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq. Nat. Protoc. 16, 5592\u20135615 (2021).","journal-title":"Nat. Protoc."},{"key":"1499_CR50","doi-asserted-by":"publisher","unstructured":"Lazzarotto, C. R. et al. Population-scale cellular GUIDE-seq-2 and biochemical CHANGE-seq-R profiles reveal human genetic variation frequently affects Cas9 off-target activity. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.10.637517 (2025).","DOI":"10.1101\/2025.02.10.637517"},{"key":"1499_CR51","doi-asserted-by":"publisher","unstructured":"Lazzarotto, C. R. et al. CHANGE-seq-BE enables simultaneously sensitive and unbiased in vitro profiling of base editor genome-wide activity. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.03.28.586621 (2024).","DOI":"10.1101\/2024.03.28.586621"},{"key":"1499_CR52","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","volume":"38","author":"CR Lazzarotto","year":"2020","unstructured":"Lazzarotto, C. R. et al. CHANGE-seq reveals genetic and epigenetic effects on CRISPR\u2013Cas9 genome-wide activity. Nat. Biotechnol. 38, 1317\u20131327 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1152\/physiolgenomics.00054.2002","volume":"10","author":"H-B Xin","year":"2002","unstructured":"Xin, H.-B., Deng, K.-Y., Rishniw, M., Ji, G. & Kotlikoff, M. I. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice. Physiol. Genomics 10, 211\u2013215 (2002).","journal-title":"Physiol. Genomics"},{"key":"1499_CR54","first-page":"E5569","volume":"114","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Vascular disease-causing mutation, smooth muscle \u03b1-actin R258C, dominantly suppresses functions of \u03b1-actin in human patient fibroblasts. Proc. Natl Acad. Sci. USA 114, E5569\u2013E5578 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1499_CR55","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature 589, 608\u2013614 (2021).","journal-title":"Nature"},{"key":"1499_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1499_CR57","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1089\/hum.2022.211","volume":"34","author":"SH Ramirez","year":"2023","unstructured":"Ramirez, S. H. et al. An engineered adeno-associated virus capsid mediates efficient transduction of pericytes and smooth muscle cells of the brain vasculature. Hum. Gene Ther. 34, 682\u2013696 (2023).","journal-title":"Hum. Gene Ther."},{"key":"1499_CR58","first-page":"e471","volume":"150","author":"Y Kim","year":"2024","unstructured":"Kim, Y. et al. Gene therapy in cardiovascular disease: recent advances and future directions in science: a science advisory from the American Heart Association. Circulation 150, e471\u2013e480 (2024).","journal-title":"Circulation"},{"key":"1499_CR59","unstructured":"Kleinstiver, B. & Walton, R. T. Crispr-Cas enzymes with enhanced on-target activity (2021)."},{"key":"1499_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"1499_CR61","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nbt.3404","volume":"33","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR\u2013Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293\u20131298 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR62","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-018-0011-0","volume":"37","author":"BP Kleinstiver","year":"2019","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276\u2013282 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR63","volume":"3","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Synergistic engineering of CRISPR\u2013Cas nucleases enables robust mammalian genome editing. Innovation 3, 100264 (2022).","journal-title":"Innovation"},{"key":"1499_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30465-7","volume":"13","author":"C McGaw","year":"2022","unstructured":"McGaw, C. et al. Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing. Nat. Commun. 13, 2833 (2022).","journal-title":"Nat. Commun."},{"key":"1499_CR65","first-page":"540","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. An engineered xCas12i with high activity, high specificity, and broad PAM range. Protein Cell 14, 540\u2013545 (2023).","journal-title":"Protein Cell"},{"key":"1499_CR66","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41589-024-01669-3","volume":"20","author":"H Yan","year":"2024","unstructured":"Yan, H. et al. Assessing and engineering the IscB-\u03c9RNA system for programmed genome editing. Nat. Chem. Biol. 20, 1617\u20131628 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"1499_CR67","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41589-023-01380-9","volume":"19","author":"T Wu","year":"2023","unstructured":"Wu, T. et al. An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity. Nat. Chem. Biol. 19, 1384\u20131393 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1499_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41589-024-01706-1","volume":"21","author":"Q Xiao","year":"2025","unstructured":"Xiao, Q. et al. Engineered IscB-\u03c9RNA system with expanded target range for base editing. Nat. Chem. Biol. 21, 100\u2013108 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"1499_CR69","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-025-09021-y","volume":"643","author":"RA Silverstein","year":"2025","unstructured":"Silverstein, R. A. et al. Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learning. Nature 643, 539\u2013550 (2025).","journal-title":"Nature"},{"key":"1499_CR70","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","volume":"392","author":"K Musunuru","year":"2025","unstructured":"Musunuru, K. et al. Patient-specific in vivo gene editing to treat a rare genetic disease. N. Engl. J. Med. 392, 2235\u20132243 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1499_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50340-x","volume":"15","author":"J Lin","year":"2024","unstructured":"Lin, J. et al. Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model. Nat. Commun. 15, 5927 (2024).","journal-title":"Nat. Commun."},{"key":"1499_CR72","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","volume":"6","author":"JR Davis","year":"2022","unstructured":"Davis, J. R. et al. Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors. Nat. Biomed. Eng. 6, 1272\u20131283 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1499_CR73","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/genbio.2022.0015","volume":"1","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Adenine base editing in vivo with a single adeno-associated virus vector. GEN Biotechnol. 1, 285\u2013299 (2022).","journal-title":"GEN Biotechnol."},{"key":"1499_CR74","doi-asserted-by":"publisher","unstructured":"Liu, Z. et al. An all-in-one AAV vector for cardiac-specific gene silencing by an adenine base editor. 2024.09.30.615742 Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.30.615742 (2024).","DOI":"10.1101\/2024.09.30.615742"},{"key":"1499_CR75","doi-asserted-by":"publisher","first-page":"e2307796121","DOI":"10.1073\/pnas.2307796121","volume":"121","author":"CA Tsuchida","year":"2024","unstructured":"Tsuchida, C. A., Wasko, K. M., Hamilton, J. R. & Doudna, J. A. Targeted nonviral delivery of genome editors in vivo. Proc. Natl Acad. Sci. USA 121, e2307796121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1499_CR76","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","volume":"19","author":"J Kim","year":"2024","unstructured":"Kim, J., Eygeris, Y., Ryals, R. C., Jozic, A. & Sahay, G. Strategies for non-viral vectors targeting organs beyond the liver. Nat. Nanotechnol. 19, 428\u2013447 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"1499_CR77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343\u2013345 (2009).","journal-title":"Nat. Methods"},{"key":"1499_CR78","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1101\/gr.128124.111","volume":"22","author":"N Rohland","year":"2012","unstructured":"Rohland, N. & Reich, D. Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture. Genome Res. 22, 939\u2013946 (2012).","journal-title":"Genome Res."},{"key":"1499_CR79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR80","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/hmg\/ddab093","volume":"30","author":"S DeRosa","year":"2021","unstructured":"DeRosa, S. et al. MCOLN1 gene therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV. Hum. Mol. Genet. 30, 908\u2013922 (2021).","journal-title":"Hum. Mol. Genet."},{"key":"1499_CR81","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1126\/science.abb1390","volume":"369","author":"A Lapinaite","year":"2020","unstructured":"Lapinaite, A. et al. DNA capture by a CRISPR-Cas9-guided adenine base editor. Science 369, 566\u2013571 (2020).","journal-title":"Science"},{"key":"1499_CR82","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41587-019-0050-1","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Kim, D., Lee, G., Cho, S.-I. & Kim, J.-S. Genome-wide target specificity of CRISPR RNA-guided adenine base editors. Nat. Biotechnol. 37, 430\u2013435 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1499_CR83","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtm.2019.10.007","volume":"15","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. Selection of an efficient AAV vector for robust CNS transgene expression. Mol. Ther. Methods Clin. Dev. 15, 320\u2013332 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1499_CR84","unstructured":"Alves, C. R. R. et al. Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice. NCBI https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA1280096 (2025)."},{"key":"1499_CR85","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.febslet.2009.02.003","volume":"583","author":"J Zettler","year":"2009","unstructured":"Zettler, J., Sch\u00fctz, V. & Mootz, H. D. The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett. 583, 909\u2013914 (2009).","journal-title":"FEBS Lett."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01499-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:04:00Z","timestamp":1779314640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01499-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1499"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01499-1","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.L.L.C., R.M., C.A.M., D.Y.C., B.P.K., M.E.L. and P.L.M. are inventors on a patent application filed by MGB that describes the development of genome-editing technologies to treat MSMDS. C.R.R.A., R.A.S., J.F.d.S. and B.P.K. are inventors on additional patents or patent applications filed by MGB that describe genome engineering technologies. C.R.R.A. is a consultant for Biogen and Ilios Therapeutics. S.Q.T. is an inventor on a patent covering CHANGE-seq. S.Q.T. is a member of the scientific advisory board of Prime Medicine and Ensoma. R.M., D.Y.C., C.A.M., B.P.K., M.E.L. and P.L.M. received sponsored research support from Angea Biotherapeutics, a company developing gene therapies for vasculopathies. R.M. receives research funding from Amgen, serves as a consultant for Pharmacosmos, Myokardia\/BMS, Renovacor, Epizon Pharma and Third Pole, and performs speaker bureaus through Vox Media, all of which are unrelated to the current work. C.A.M. has financial interests in Chameleon Biosciences, Skylark Bio and Sphere Gene Therapeutics, companies developing adeno-associated virus vector technologies for gene therapy applications; C.A.M. performs paid consulting work for all three companies. C.A.M.\u2019s interests were reviewed and are managed by MGH and MGB in accordance with their conflict-of-interest policies. B.P.K. is a consultant for EcoR1 capital, Novartis Venture Fund, Foresite Labs and Jumble Therapeutics, and is on the scientific advisory boards of Acrigen Biosciences, Life Edit Therapeutics and Prime Medicine. B.P.K. has a financial interest in Prime Medicine, a company developing therapeutic CRISPR\u2013Cas technologies for gene editing. B.P.K.\u2019s interests were reviewed and are managed by MGH and MGB in accordance with their conflict-of-interest policies. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}